Bluejay Diagnostics, Inc. (NASDAQ:BJDX) Short Interest Down 9.4% in September

Bluejay Diagnostics, Inc. (NASDAQ:BJDX) was the recipient of a significant decrease in short interest in September. As of September 15th, there was short interest totalling 97,700 shares, a decrease of 9.4% from the August 31st total of 107,800 shares. Approximately 0.6% of the company’s stock are sold short. Based on an average daily volume of 2,070,000 shares, the days-to-cover ratio is presently 0.0 days.

Hedge Funds Weigh In On Bluejay Diagnostics

A hedge fund recently bought a new stake in Bluejay Diagnostics stock. Armistice Capital LLC acquired a new stake in Bluejay Diagnostics, Inc. (NASDAQ:BJDX) in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor acquired 24,230 shares of the company’s stock, valued at approximately $30,000. Armistice Capital LLC owned 1.95% of Bluejay Diagnostics at the end of the most recent quarter. 18.47% of the stock is owned by institutional investors and hedge funds.

Bluejay Diagnostics Price Performance

BJDX remained flat at $0.14 on Friday. The company had a trading volume of 1,388,360 shares, compared to its average volume of 749,909. The business has a fifty day simple moving average of $0.29 and a 200 day simple moving average of $2.66. The company has a market capitalization of $47,073.60, a P/E ratio of 0.00 and a beta of 0.73. Bluejay Diagnostics has a 52-week low of $0.13 and a 52-week high of $38.96.

Bluejay Diagnostics (NASDAQ:BJDX) last announced its quarterly earnings results on Wednesday, August 14th. The company reported ($5.12) earnings per share (EPS) for the quarter.

About Bluejay Diagnostics

Bluejay Diagnostics, Inc, a medical diagnostic company, develops rapid test for the monitoring of disease progression in the United States. It is developing Symphony platform, a technology platform comprising Symphony analyzer that orchestrates blood processing, biomarker isolation, and immunoassay preparation using non-contact centrifugal force; and Symphony Cartridge, which includes reagents and components.